252 related articles for article (PubMed ID: 35960442)
1. A Systematic Review of Vitamin D and Fibroids: Pathophysiology, Prevention, and Treatment.
Combs A; Singh B; Nylander E; Islam MS; Nguyen HV; Parra E; Bello A; Segars J
Reprod Sci; 2023 Apr; 30(4):1049-1064. PubMed ID: 35960442
[TBL] [Abstract][Full Text] [Related]
2. Selective progesterone receptor modulators (SPRMs) for uterine fibroids.
Murji A; Whitaker L; Chow TL; Sobel ML
Cochrane Database Syst Rev; 2017 Apr; 4(4):CD010770. PubMed ID: 28444736
[TBL] [Abstract][Full Text] [Related]
3. Role of vitamin D in uterine fibroid biology.
Brakta S; Diamond JS; Al-Hendy A; Diamond MP; Halder SK
Fertil Steril; 2015 Sep; 104(3):698-706. PubMed ID: 26079694
[TBL] [Abstract][Full Text] [Related]
4. Mifepristone for uterine fibroids.
Tristan M; Orozco LJ; Steed A; Ramírez-Morera A; Stone P
Cochrane Database Syst Rev; 2012 Aug; 2012(8):CD007687. PubMed ID: 22895965
[TBL] [Abstract][Full Text] [Related]
5. Safety and efficacy of the selective progesterone receptor modulator asoprisnil for heavy menstrual bleeding with uterine fibroids: pooled analysis of two 12-month, placebo-controlled, randomized trials.
Stewart EA; Diamond MP; Williams ARW; Carr BR; Myers ER; Feldman RA; Elger W; Mattia-Goldberg C; Schwefel BM; Chwalisz K
Hum Reprod; 2019 Apr; 34(4):623-634. PubMed ID: 30865281
[TBL] [Abstract][Full Text] [Related]
6. The management of uterine fibroids in women with otherwise unexplained infertility.
Carranza-Mamane B; Havelock J; Hemmings R; ;
J Obstet Gynaecol Can; 2015 Mar; 37(3):277-285. PubMed ID: 26001875
[TBL] [Abstract][Full Text] [Related]
7. Preoperative medical therapy before surgery for uterine fibroids.
Lethaby A; Puscasiu L; Vollenhoven B
Cochrane Database Syst Rev; 2017 Nov; 11(11):CD000547. PubMed ID: 29139105
[TBL] [Abstract][Full Text] [Related]
8. Pre-operative GnRH analogue therapy before hysterectomy or myomectomy for uterine fibroids.
Lethaby A; Vollenhoven B; Sowter M
Cochrane Database Syst Rev; 2001; (2):CD000547. PubMed ID: 11405968
[TBL] [Abstract][Full Text] [Related]
9. The management of uterine leiomyomas.
Vilos GA; Allaire C; Laberge PY; Leyland N;
J Obstet Gynaecol Can; 2015 Feb; 37(2):157-178. PubMed ID: 25767949
[TBL] [Abstract][Full Text] [Related]
10. Progestogens or progestogen-releasing intrauterine systems for uterine fibroids.
Sangkomkamhang US; Lumbiganon P; Laopaiboon M; Mol BW
Cochrane Database Syst Rev; 2013 Feb; (2):CD008994. PubMed ID: 23450594
[TBL] [Abstract][Full Text] [Related]
11. Effect of oral consumption of vitamin D on uterine fibroids: A randomized clinical trial.
Arjeh S; Darsareh F; Asl ZA; Azizi Kutenaei M
Complement Ther Clin Pract; 2020 May; 39():101159. PubMed ID: 32379687
[TBL] [Abstract][Full Text] [Related]
12. Quality of life with relugolix combination therapy for uterine fibroids: LIBERTY randomized trials.
Stewart EA; Lukes AS; Venturella R; Li Y; Hunsche E; Wagman RB; Al-Hendy A
Am J Obstet Gynecol; 2023 Mar; 228(3):320.e1-320.e11. PubMed ID: 36370871
[TBL] [Abstract][Full Text] [Related]
13. Vitamin D and Uterine Fibroids-Review of the Literature and Novel Concepts.
Ciebiera M; Włodarczyk M; Ciebiera M; Zaręba K; Łukaszuk K; Jakiel G
Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 30011902
[TBL] [Abstract][Full Text] [Related]
14. Hypovitaminosis D and "small burden" uterine fibroids: Opportunity for a vitamin D supplementation.
Ciavattini A; Delli Carpini G; Serri M; Vignini A; Sabbatinelli J; Tozzi A; Aggiusti A; Clemente N
Medicine (Baltimore); 2016 Dec; 95(52):e5698. PubMed ID: 28033263
[TBL] [Abstract][Full Text] [Related]
15. Pre-operative GnRH analogue therapy before hysterectomy or myomectomy for uterine fibroids.
Lethaby A; Vollenhoven B; Sowter M
Cochrane Database Syst Rev; 2000; (2):CD000547. PubMed ID: 10796723
[TBL] [Abstract][Full Text] [Related]
16. The Mediator Complex Subunit 12 (MED-12) Gene and Uterine Fibroids: a Systematic Review.
Amendola ILS; Spann M; Segars J; Singh B
Reprod Sci; 2024 Feb; 31(2):291-308. PubMed ID: 37516697
[TBL] [Abstract][Full Text] [Related]
17. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
18. Progestogens or progestogen-releasing intrauterine systems for uterine fibroids (other than preoperative medical therapy).
Sangkomkamhang US; Lumbiganon P; Pattanittum P
Cochrane Database Syst Rev; 2020 Nov; 11(11):CD008994. PubMed ID: 33226133
[TBL] [Abstract][Full Text] [Related]
19. Guideline No. 389-Medical Management of Symptomatic Uterine Leiomyomas - An Addendum.
Laberge PY; Murji A; Vilos GA; Allaire C; Leyland N; Singh SS
J Obstet Gynaecol Can; 2019 Oct; 41(10):1521-1524. PubMed ID: 31548041
[TBL] [Abstract][Full Text] [Related]
20. Herbal preparations for uterine fibroids.
Liu JP; Yang H; Xia Y; Cardini F
Cochrane Database Syst Rev; 2013 Apr; (4):CD005292. PubMed ID: 23633329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
